Role of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib in the Management of Neuroblastoma
Authors
Yasemin Benderli Cihan
Kayseri Education and Research Hospital, Department of Radiation Oncology,, Kayseri, Turkey
DOI: https://doi.org/10.2478/sjecr-2018-0066 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Language: English
Submitted on: Dec 4, 2018
Accepted on: Jul 27, 2018
Published on: Jan 10, 2019
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2019 Yasemin Benderli Cihan, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.